Drug intelligence / Profile preview

shihu yeguang wan

Development stage: Unknown
Lead developer: Guiyang Dechangxiang Pharmaceutical
Administration: Oral

Overview

Shihu Yeguang Wan is a traditional Chinese medicine (TCM) formulation manufactured by Guiyang Dechangxiang Pharmaceutical. It is a classic prescription composed of 25 herbal and mineral ingredients, including Dendrobium, Ginseng, Rehmannia, and Poria. The medicine is traditionally used to nourish the liver and kidneys, clear internal heat, and improve eyesight. It is specifically indicated for conditions resulting from liver and kidney yin deficiency, such as blurred vision, early-stage cataracts, glaucoma, and optic atrophy. In the context of TCM theory, it works by balancing the body's internal environment to restore ocular health.

Brand names: 石斛夜光丸
Other names: Shihu Yeguang WanDendrobium Night-Brightening Pill

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on shihu yeguang wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shihu yeguang wan.

Explore the full profile